Fig. 4From: Multilayer network analysis of the drugs development cycle in the global pharmaceutical industryOverview of the MLN representation. We used the drug pipeline, supply chain, and ownership data to define the MLN (\(M=3\)), which is composed of firms and institutions as nodes. Then, we construct MLN for knowledge flow based on the edge attribution about the status of the drug pipelineBack to article page